Related references
Note: Only part of the references are listed.Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients
Nika Kianfar et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid
H. Rashid et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
The treatment of refractory atypical bullous pemphigoid with generalized eczema and intense pruritus with dupilumab
Wei Li et al.
DERMATOLOGIC THERAPY (2022)
Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review
Yuliya Lytvyn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid
Lula Maria Nieto-Benito et al.
EXPERIMENTAL DERMATOLOGY (2022)
Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real-life study
M. Velin et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
The global incidence of bullous pemphigoid: a systematic review and meta-analysis
M. S. M. Persson et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review
Aleksi J. Hendricks et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient
Francisco J. Navarro-Trivino et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2021)
Refractory bullous pemphigoid with IgE anti-BP230 and IgG anti-p200 antibodies successfully treated with oma-lizumab
M. Sarrazin et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2021)
Onset of acquired haemophilia A after omalizumab treatment in severe bullous pemphigoid - a report on two cases successfully treated with mycophenolate mofetil
M. -A. Mangin et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2021)
A retrospective cohort study reporting rituximab treatment for 33 patients with immunobullous disease
Nicola Watson et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)
Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients
Xiuting Liu et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2021)
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
S. Morteza Seyed Jafari et al.
FRONTIERS IN IMMUNOLOGY (2021)
Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
Si-Hang Wang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
Yihua Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities
D. De et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter
Yihua Zhang et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results
A. Kamata et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series
Rana Abdat et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
S1933 An Unexpected Cause of Dysphagia in a Patient Hospitalized for Nephrectomy
Scott Wardlaw et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Efficacy and Safety of Rituximab in Immunobullous Diseases: A Retrospective Study from a Tertiary Care Centre of Nepal
Sudip Parajuli et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2020)
Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients
Maxim Polansky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Highlighting The Role OF IgE Autoantibodies In Bullous Pemphigoid
Sam Salman et al.
PATHOLOGY (2019)
Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid
S. Morteza Seyed Jafari et al.
FRONTIERS IN IMMUNOLOGY (2019)
Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature
Noa Kremer et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid
Talia James et al.
CLINICAL IMMUNOLOGY (2019)
Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report
Cristina Vico-Alonso et al.
DERMATOLOGIC THERAPY (2019)
Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab
Roberto Maglie et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2019)
B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid
Berkani Nicolas et al.
SCIENTIFIC REPORTS (2019)
Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid
Sebastien Menzinger et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid
Alyson V. Ridpath et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Dupilumab for treatment of atopic dermatitis
Marlene Seegraeber et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
IgE bullous pemphigoid and nodular regenerative hyperplasia of the liver in a patient with heterozygous alpha1-antitrypsin deficiency
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid
Alex Kaye et al.
JAMA DERMATOLOGY (2018)
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity
Nina van Beek et al.
JAMA DERMATOLOGY (2017)
Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin
T. Nguyen et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Bullous Pemphigoid Successfully Treated with Rituximab
Nuno Silva et al.
ACTA MEDICA PORTUGUESA (2017)
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
Asli Bilgic Temel et al.
CASE REPORTS IN DERMATOLOGY (2017)
Comparable actions of omalizumab on mast cells and basophils
E. Serrano-Candelas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Childhood bullous pemphigoid: a report of three cases in China
Baoqi Yang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Bullous pemphigoid successfully treated with omalizumab
Muzeyyen Gonul et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2016)
Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up
A. Razzaque Ahmed et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature
G. Balakirski et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients
D. Tomsitz et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
Y. T. Cho et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
C. Feliciani et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Infectious complications in bullous pemphigoid: An analysis of risk factors
Yee Wei Phoon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab
Yong He et al.
JAMA DERMATOLOGY (2015)
An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
K. T. Amber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate
Ting-Shun Wang et al.
ACTA DERMATO-VENEREOLOGICA (2014)
Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid
K. A. N. Messingham et al.
IMMUNOLOGIC RESEARCH (2014)
Bullous Pemphigoid Associated with Acquired Hemophilia A: A Rare Association of Autoimmune Disease
Mohammed I. AlJasser et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2014)
Treatment of recalcitrant bullous pemphigoid with rituximab
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
M. Kolesnik et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
New strategies with anti-IgE in allergic diseases
Stephen T. Holgate
WORLD ALLERGY ORGANIZATION JOURNAL (2014)
Refractory bullous pemphigoid with fatal outcome in a young patient
Maria Joao Cruz et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
Russell P. Hall et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Refractory Childhood Pemphigoid Successfully Treated with Rituximab
Irene Fuertes et al.
PEDIATRIC DERMATOLOGY (2013)
Successful Treatment of Bullous Pemphigoid With Omalizumab
Vanessa A. London et al.
ARCHIVES OF DERMATOLOGY (2012)
Successful management of severe infant bullous pemphigoid with omalizumab
C. Dufour et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab
X. Zhang et al.
HAEMOPHILIA (2012)
Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis
S. Yayli et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
Michael Kasperkiewicz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients
S. Lourari et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Analysis of Current Therapy and Clinical Outcome in Childhood Pemphigus Vulgaris
Dalia Mabrouk et al.
PEDIATRIC DERMATOLOGY (2011)
Efficacy of rituximab in a case of refractory bullous pemphigoid
Z. Reguiai et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2009)
Omalizumab: overview of pharmacology and efficacy in asthma
Dennis Keith Ledford
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
Janet A. Fairley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
B Cells and Immunological Tolerance
Nataly Manjarrez-Orduno et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
DRUG THERAPY Asthma
Christopher H. Fanta
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Severe bullous pemphigoid in an infant - Successful treatment with rituximab
Johannes Schulze et al.
PEDIATRIC DERMATOLOGY (2008)
A new approach on bullous pemphigoid therapy
Z. Saouli et al.
ANNALS OF ONCOLOGY (2008)
Rituximab in autoimmune bullous diseases:: mixed responses and adverse effects
E. Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Case report - Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease
P Szabolcs et al.
BONE MARROW TRANSPLANTATION (2002)
Share Paper
